T Tsunoda
Overview
Explore the profile of T Tsunoda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
344
Citations
2690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Honma O, Watanabe C, Fukuchimoto H, Kashiwazaki J, Tateba M, Wagatsuma S, et al.
Front Pharmacol
. 2022 Feb;
13:744916.
PMID: 35222016
Proper management of adverse events is crucial for the safe and effective implementation of anticancer drug treatment. Showa University Hospital uses our interview sheet (assessment and risk control [ARC] sheet)...
2.
Morales Vargas R, Tsunoda T, Noda J, Bousses P, Nguyen T, Hasebe F, et al.
Infect Genet Evol
. 2021 Feb;
90:104764.
PMID: 33581329
Background: Japanese encephalitis is a severe disease of acute encephalitis, with children and the elderly primarily affected, and with mortality rates reaching over 25%. The virus is transmitted mainly by...
3.
Hayashi M, Tsunoda T, Sato F, Yaguchi Y, Igarashi M, Izumi K, et al.
Br J Dermatol
. 2019 Sep;
182(3):806-807.
PMID: 31498425
No abstract available.
4.
Chang S, McDonough C, Gong Y, Johnson T, Tsunoda T, Gamazon E, et al.
Pharmacogenomics J
. 2016 Sep;
18(1):106-112.
PMID: 27670767
We conducted a discovery genome-wide association study with expression quantitative trait loci (eQTL) annotation of new-onset diabetes (NOD) among European Americans, who were exposed to a calcium channel blocker-based strategy...
5.
Wong A, Soo R, Tan D, Lee S, Lim J, Marban P, et al.
Ann Oncol
. 2015 Jan;
26(5):998-1005.
PMID: 25609248
Background: The aim of this study was to determine the maximum-tolerated dose (MTD), safety, pharmacokinetics, and pharmacodynamics of OPB-51602, an oral, direct signal transduction activator of transcription 3 (STAT3) inhibitor,...
6.
Okamoto N, Miya F, Tsunoda T, Kato M, Saitoh S, Yamasaki M, et al.
Clin Genet
. 2014 Aug;
88(3):288-92.
PMID: 25156961
We developed a next-generation sequencing (NGS) based mutation screening strategy for neurodevelopmental diseases. Using this system, we screened 284 genes in 40 patients. Several novel mutations were discovered. Patient 1...
7.
Urakami A, Yoshida K, Hirabayashi Y, Kubota H, Yamashita K, Hirai T, et al.
Asian J Endosc Surg
. 2012 Jul;
4(4):185-8.
PMID: 22776306
A rare case of an epidermoid cyst originating in an intrapancreatic accessory spleen in a 50-year-old Japanese female is reported. A hypoechoic cystic tumor was detected incidentally by abdominal ultrasonography....
8.
Mikura S, Wada H, Okazaki M, Nakamura M, Honda K, Yasutake T, et al.
J Hosp Infect
. 2011 Aug;
79(3):267-8.
PMID: 21864937
We studied the risk factors associated with resistance to imipenem, levofloxacin and gentamicin in Pseudomonas aeruginosa isolated from blood cultures of 175 patients in a hospital in Japan. Imipenem resistance...
9.
Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Noguchi K, et al.
Oncol Rep
. 2011 May;
3(1):45-8.
PMID: 21594313
The autologous mixed lymphocyte reaction (AMLR) represents a self recognitive response, which is very important in the immunoregulatory network system. We investigated whether the AMLR activity of patients with gastric...
10.
Noguchi K, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tani M, et al.
Oncol Rep
. 2011 May;
4(5):927-30.
PMID: 21590168
We investigated the in vivo augmentation of susceptibility of tumor cells to tumor-infiltrating lymphocytes (TILs) with cisplatin (CDDP). TILs showed cytotoxicity against autologous and established tumor cells. Pretreatment of tumor...